Millennium Management’s Abiomed Inc ABMD Stock Holding History

Millennium Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,000	Closed	-$1.63M	–	7646
2021 Q3	$1.63M	Buy	+5,000	New	+$1.69M	﹤0.01%	4153
2021 Q2	–	Sell	-17,500	Closed	-$5.58M	–	7342
2021 Q1	$5.58M	Buy	17,500 +5,000	+40%	+$1.6M	﹤0.01%	2448
2020 Q4	$4.05M	Buy	+12,500	New	+$3.46M	﹤0.01%	2651
2020 Q1	–	Sell	-65,000	Closed	-$11.1M	–	4720
2019 Q4	$11.1M	Buy	65,000 +62,000	+2,067%	+$11.5M	0.01%	1299
2019 Q3	$533K	Buy	+3,000	New	+$648K	﹤0.01%	3210
2014 Q1	–	Sell	-40,200	Closed	-$1.07M	–	3992
2013 Q4	$1.07M	Sell	40,200 -34,800	-46%	-$860K	﹤0.01%	2234
2013 Q3	$1.43M	Buy	+75,000	New	+$1.71M	﹤0.01%	1891

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's ABMD Position: Q4 2022 in Review

Millennium Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 9,614 shares — an estimated $2.36M sold.

Millennium Management first reported a position in ABMD in Q2 2013 and held it in 37 quarters. The position peaked at $85.2M in Q4 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Millennium Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 9,614 Abiomed Inc shares in Q4 2022, an estimated $2.36M.
Millennium Management first reported a position in Abiomed Inc in Q2 2013 and held it in 37 quarters.
Millennium Management's Abiomed Inc position peaked at $85.2M in Q4 2017.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.